Research synthesisVery low evidenceModerate effect13 studies · 13 beneficial · 0 neutral · 0 harmful
Across 13 studies, 13 reported beneficial effects of *Lactobacillus rhamnosus* on reduced inflammation, with a predominant moderate effect size. Only 2 studies reached statistical significance, both in animal models, and the evidence is largely from low-quality studies (in vitro, animal, or narrative reviews) rather than high-quality human RCTs. No consistent dose range or study duration was reported across the available evidence.
- Studied populations: pediatric asthma patients; patients with non-dialysis chronic kidney disease (stage 3-5); children and adults with allergic diseases
Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Most studies are in vitro or animal models, and only two human clinical trials are included, one of which lacked a sample size. Dose, form, and duration data are largely missing, limiting practical applicability.
Generated Jun 11, 2026